WHITE PAPER | OCT 01, 2025

What is ICH GCP, and How Does It Impact Clinical Planning?

The July 2025 ICH GCP update brings new standards for clinical trials, focusing on flexibility, risk management, and patient engagement.

Key Takeaways:

  • Supports digital and decentralized trial designs for greater efficiency 
  • Requires proactive risk assessment and quality management
  • Strengthens data integrity and transparency standards
  • Encourages early patient involvement and diversity in trials
  • Clarifies stakeholder roles for better collaboration
PDF preview of the What Is ICH GCP and How Does It Impact Clinical Planning white paper available for download.
Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.
The new GCP guideline aligns transparency expectations with ethical principles like the Declaration of Helsinki, creating a unified global approach that provides consistency across all markets.
Francine Lane, Head of Transparency, Citeline

Related resources

A healthcare professional reviews digital documents with checklists while working on a laptop.
AUG 21, 2025
Article
Clinical

ICH E6(R3)改訂のポイントと臨床試験への影響:よくある質問10選

The updated Good Clinical Practice (GCP) guideline redefines quality, oversight, and transparency in trials. Find out what’s changed — and how Citeline can help you comply.

''
APR 16, 2025
Article
薬事規制関連支援サービス

GCP in 2025: A Transparency Revolution

See what the GCP Guidance updates mean for disclosure, plain language, and participant trust in terms of clinical research transparency.

''
MAY 12, 2025
Article
Clinical

Citeline Elevate Spring 2025: Brainpower in Boston

Citeline Elevate Spring 2025, “Pharma Futurology: Clinical and Technical Innovation,” brought together a group of highly engaged pharmaceutical professionals for a day of informative sessions and informal networking.